-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Q1 EPS Estimates for Cogent Biosciences Lifted by Wedbush
Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) – Equities research analysts at Wedbush increased their Q1 2025 EPS estimates for Cogent Biosciences in a research note issued to investors on Tuesday, February 25th. Wedbush analyst D. Nierengarten now forecasts that the technology company will post earnings per share of ($0.44) for the quarter, up from […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) – Equities research analysts at Wedbush increased their Q1 2025 EPS estimates for Cogent Biosciences in a research note issued to investors on Tuesday, February 25th. Wedbush analyst D. Nierengarten now forecasts that the technology company will post earnings per share of ($0.44) for the quarter, up from […]
